למיקטל טבליות מסיסות/לעיסות 50 מ"ג

País: Israel

Idioma: hebreu

Font: Ministry of Health

ingredients actius:

LAMOTRIGINE 50 MG

Disponible des:

GLAXO SMITH KLINE (ISRAEL) LTD

Codi ATC:

N03AX09

formulario farmacéutico:

DISPERSIBLE/CHEWABLE TABLETS

Vía de administración:

PER OS

Fabricat per:

GLAXO WELLCOME OPERATIONS LTD, UK

Grupo terapéutico:

LAMOTRIGINE

indicaciones terapéuticas:

Epilepsy: Monotherapy in adults and children over 12 years of age: 1. Simple partial seizures. 2. complex partial seizures. 3. generalised tonic clonic secondarily seizures. 4. Primary generalised tonic clonic seizures. Add-on therapy in adults and children over 2 years of age: 1. Simple partial seizures. 2. Complex partial seizures. 3. Secondarily generalised tonic clonic seizures. Adults (18 years of age and over) Lamotrigine is indicated for the prevention of mood episodes in patients with bipolar disorder predominantly by preventing depressive episodes.

Data d'autorització:

2008-11-01